Edwards Lifesciences Corp. (EW)
83.88
-1.34
(-1.57%)
USD |
NYSE |
Mar 05, 16:00
83.88
0.00 (0.00%)
After-Hours: 17:33
Edwards Lifesciences Cash from Investing (Quarterly) : -198.30M for Dec. 31, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Boston Scientific Corp. | -512.00M |
| Intuitive Surgical, Inc. | -209.40M |
| Abbott Laboratories | -913.00M |
| Artivion, Inc. | -30.51M |
| AtriCure, Inc. | -2.602M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 450.90M |
| Cash from Financing (Quarterly) | -11.40M |
| Free Cash Flow | 1.335B |
| Free Cash Flow Per Share (Quarterly) | 0.6076 |
| Free Cash Flow to Equity (Quarterly) | 348.40M |
| Free Cash Flow to Firm (Quarterly) | 353.50M |
| Free Cash Flow Yield | 2.72% |